Supported by NEI Grants EY11008, P30 EY022589, EY026590, EY022039, EY021818, EY023704, EY029058, T32 EY026590, R21 EY027945, and an unrestricted grant from Research to Prevent Blindness (New York, NY).
Disclosure: M. Christopher, None; K. Nakahara, None; C. Bowd, None; J.A. Proudfoot, None; A. Belghith, None; M.H. Goldbaum, None; J. Rezapour, German Research Foundation (DFG, research fellowship grant RE 4155/1-1) (F), German Ophthalmological Society (DOG) (F); R.N. Weinreb, Aerie Pharmaceuticals (C), Allergan (C), Eyenovia (C), Implantdata (C), Unity (C), Heidelberg Engineering (F), Carl Zeiss Meditec (F), Centervue (F), Bausch & Lomb (F), Genentech (F), Konan Medical (F), National Eye Institute (F), Optos (F), Optovue Research to Prevent Blindness (F); M.A. Fazio, National Eye Institute (F), EyeSight Foundation of Alabama (F), Research to Prevent Blindness (F), Heidelberg Engineering (F); C.A. Girkin, National Eye Institute (F), EyeSight Foundation of Alabama (F), Research to Prevent Blindness (F), Heidelberg Engineering (F); J.M. Liebmann, Aerie Pharmaceuticals, Alcon, Allergan, Bausch & Lomb, Carl Zeiss Meditec, Eyenovia, Galimedix, Heidelberg Engineering, Zeiss Meditec, National Eye Institute, Novartis, Research to Prevent Blindness, Inc.; G. De Moraes, Novartis (C), Galimedix (C), Belite (C), Reichert (C), Carl Zeiss Meditec (C), Heidelberg Engineering (F), Topcon (F); H. Murata, The Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 25861618) (F); K. Tokumo, None; N. Shibata, None; Y. Fujino, The Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 20768254) (F); M. Matsuura, The Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 00768351) (F); Y. Kiuchi, None; M. Tanito, None; R. Asaoka, The Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant number 18KK0253, 19H01114 and 17K11418) (F), Daiichi Sankyo Foundation of Life Science, Suzuken Memorial Foundation, The Translational Research program, Japan Agency for Medical Research and Development (AMED, Strategic Promotion for Practical Application of Innovative Medical Technology [TR-SPRINT]); L.M. Zangwill, Carl Zeiss Meditec (F), Heidelberg Engineering (F), National Eye Institute (F), BrightFocus Foundation (F), Optovue (F), Topcon Medical System Inc. (F)